IP Library Granted Patent US 8,227,231
Granted Patent B2
US 8,227,231 · App. 11/997,614 · Granted Jul 24, 2012

Restriction endonucleases, DNA encoding these endonucleases and methods for identifying new endonucleases with the same or varied specificity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,227,231
App. No.
11/997,614
Granted
Jul 24, 2012
Kind
B2
Abstract

Specified restriction endonucleases have been characterized for the first time by their amino acid and DNA sequences. These sequences and those with at least 90% identity thereto have been used as probes in sequence similarity analyses to identify sequence matches in a sequence database that corresponds to novel restriction endonucleases or isoschizomers. The sequence similarity analyses includes selecting a positive sequence match from any sequence producing an expectation value of less than or equal to e-02.

Claims (3)

1. An isolated protein having at least 90% amino acid sequence identity with SEQ ID NO:116.

2. An isolated protein having an amino acid sequence identified by an Expectation value of less than or equal to e-05 in a BLAST search for detecting sequence similarity using the amino acid sequence of SEQ ID NO:116.

3. The isolated protein according to claim 2 , having restriction endonuclease activity.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2008
From: MORGAN, RICHARD D.; ROBERTS, RICHARD J.
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 020492/0691 →